Partner treatment strategies for Chlamydia and Gonorrhea: Time for a reappraisal

  12 March 2025

Epidemiological treatment for suspected Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections is recommended within 14 days of exposure to reduce symptoms and prevent loss of follow-up. A retrospective cross-sectional analysis of 141 patients found a concordance rate of 44.8% for CT and 28.1% for NG, with 59.6% of potential antibiotic overuse. Patients exposed to CT had less potential antibiotic overuse than those exposed to NG. Waiting for laboratory diagnosis before treatment could avoid nearly 60% of unnecessary antibiotic treatments in asymptomatic exposed partners.

Further reading: Infectious Diseases Now
Author(s): Lea Ben Said et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!